| Biomarker ID | 1122 |
| PMID | 23716368 |
| Year | 2013 |
| Biomarker | Acid ceramidase |
| Biomarker Basis | Concentration Based |
| Biomolecule | Protein |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Downregulated in Agressive Prostate Cancer 0.18 Fold |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | NA |
| Experiment | Agressive Vs Non Agressive Prostate Cancer |
| Type of Biomarker | Prognostic |
| Cohort | Verification Set: 12 Samples from Normal Prostate, 31 from Non Agressive Prostate Cancer and 24 Agressive Prostate Cancer set were chosen for analysis |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p = 0.04983 |
| Method Used | Liquid chromatography–mass spectrometry |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |